While BMPR2, TBX4, and SMAD9 mutations have occasionally been identified in patients with PVOD-like features, they are exceedingly rare, and their clinical relevance remains limited in PVOD, contrasted to the central role of EIF2AK4 mutations. Here, TBX4 is linked to pulmonary venoocclusive disease.